Search Results for "Immune Response To Hepatitis C Treatment"
Original Source: Immune Response to Hepatitis C Virus
The purpose of the study is to investigate the immune response to hepatitis C virus to determine why some people clear the virus and others develop chronic infection. Changes in immune response once hepatitis C therapy is begun will also be examined. If patients are also HIV+, the effect of antiretroviral therapy on the recovery of hepatitis C immunity will be investigated.
Matching Channels
Hepatitis B Immune Globulin Cangene
HepaGam B® [Hepatitis B Immune Globulin (Human) Injection] contains purified antibodies specific for the hepatitis B surface antigen (HBsAg). * It is approved in Canada and the United States f...
Hepatitis B Immune Globulin Talecris
Hepatitis B Immune Globulin Grifols
Most hepatitis C virus (HCV) infected individuals seeking treatment are chronically infected. Treatment goal is to achieve a sustained virological response (SVR), which is the absence of serum HCV R...
Matching News
Tobacco May Lower Immune System Response In Liver Transplant Recipients
Transplant recipients who smoke or have smoked increase their risk of viral hepatitis reinfection following liver transplantation according to new research available in Liver Transplantation, a journa...
Blocking A Key Protein Boosts Body's Ability To Clear Chronic Infections Like HIV, Hepatitis C
UCLA scientists have shown that temporarily blocking a protein critical to immune response actually helps the body clear itself of chronic infection. Published in the journal Science, the finding sugg...
Smoking Tied to Risk for Hepatitis Return After Liver Transplant
FRIDAY, July 27 (HealthDay News) -- Current or previous smoking may increase the risk of hepatitis reinfection in people who have a liver transplant due to viral hepatitis, a new study suggests. This...
Earlier treatment for young patients with chronic hepatitis B more effective in clearing virus
(Agency for Science, Technology and Research (A*STAR), Singapore) Scientists from A*STAR's Singapore Institute for Clinical Sciences, together with clinical collaborators from London , discovered for...
[Comment] Hepatitis C treatment: interferon free or interferon freer?
Pegylated interferon alfa-2a (peginterferon) and ribavirin are the standard of care for all six genotypes of hepatitis C virus. Hepatitis C virus (HCV) does not integrate into the human genome. Thus a...
Patient Survival Rises When Drugs Suppress Hepatitis C in Blood: Study
TUESDAY, Dec. 25 (HealthDay News) -- Patients with hepatitis C who have no detectable virus in their blood for six months after treatment are less likely to die than those who don't have this "sustain...
Sustained Virological Response to Treatment in Patients With Chronic Hepatitis C
To the Editor: Dr van der Meer and colleagues demonstrated that sustained virological response (SVR) to interferon-based treatment is associated with lower all-cause mortality among patients with chro...
Inhibiting immune response early on could speed TB treatment time, prevent relapse
Inhibiting a key immune response in mice during initial multi-drug treatment for tuberculosis could - paradoxically - shorten treatment time for the highly contagious lung infection according to new r...
Matching PubMed Articles
Hepatitis B is a major health problem with serious consequences. In hepatitis B treatment host cellular immune responses have a determinant role and T helper cells are the main active members of immun...
Altered or impaired immune response upon vaccination in WNIN/Ob rats.
The present study was aimed to study the immune response in three months old male and female naïve obese animals and upon hepatitis B vaccination in three months old female WNIN/Ob obese mutant rats,...
Hepatitis Associated Aplastic Anemia: A review.
ABSTRACT: Hepatitis-associated aplastic anemia (HAAA) is an uncommon but distinct variant of aplastic anemia in which pancytopenia appears two to three months after an acute attack of hepatitis. HAAA...
Using commercial quantitative assays, quantitative hepatitis B surface antigen (qHBsAg) has improved our understanding and management of chronic hepatitis B (CHB). The HBsAg level is highest in the im...
Treatment of chronic hepatitis B and C - update 2010.
The treatment of chronic hepatitis C and B has become more and more complex over the last years. Individualisation of therapy, depending of the natural history as well as on treatment response, is inc...
